Price Alert

Cumberland Pharmaceutical... (CPIX)

NASDAQ: CPIX · Real-Time Price · USD

3.25

-0.11 (-3.27%)

At close: Oct 14, 2025, 10:03 AM

Cumberland Pharmaceuticals Statistics

Share Statistics

Cumberland Pharmaceuticals has 14.96M shares outstanding. The number of shares has increased by 6.53% in one year.

Shares Outstanding	14.96M
Shares Change (YoY)	6.53%
Shares Change (QoQ)	-0.01%
Owned by Institutions (%)	24.63%
Shares Floating	7.97M
Failed to Deliver (FTD) Shares	95
FTD / Avg. Volume	0.18%

Short Selling Information

The latest short interest is 54.55K, so 0.36% of the outstanding shares have been sold short.

Short Interest	54.55K
Short % of Shares Out	0.36%
Short % of Float	0.62%
Short Ratio (days to cover)	1.93

Valuation Ratios

The PE ratio is -5.14 and the forward PE ratio is -6.27. Cumberland Pharmaceuticals's PEG ratio is -1.13.

PE Ratio	-5.14
Forward PE	-6.27
PS Ratio	0.88
Forward PS	1.3
PB Ratio	1.46
P/FCF Ratio	-42.08
PEG Ratio	-1.13

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Cumberland Pharmaceuticals.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.15, with a Debt / Equity ratio of 0.9.

Current Ratio	1.15
Quick Ratio	1.03
Debt / Equity	0.9
Debt / EBITDA	112.77
Debt / FCF	-25.98
Interest Coverage	-10.62

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$416.13K
Profits Per Employee	$-71.21K
Employee Count	91
Asset Turnover	0.5
Inventory Turnover	1.65

Taxes

Income Tax	-22.67K
Effective Tax Rate	0.35%

Stock Price Statistics

The stock price has increased by 156.49% in the last 52 weeks. The beta is -0.41, so Cumberland Pharmaceuticals's price volatility has been lower than the market average.

Beta	-0.41
52-Week Price Change	156.49%
50-Day Moving Average	3.3
200-Day Moving Average	3.99
Relative Strength Index (RSI)	51.58
Average Volume (20 Days)	53,820

Income Statement

In the last 12 months, Cumberland Pharmaceuticals had revenue of 37.87M and earned -6.48M in profits. Earnings per share was -0.46.

Revenue	37.87M
Gross Profit	31.28M
Operating Income	-6.43M
Net Income	-6.48M
EBITDA	182.42K
EBIT	-5.86M
Earnings Per Share (EPS)	-0.46

Full Income Statement

Balance Sheet

The company has 17.96M in cash and 20.57M in debt, giving a net cash position of -2.61M.

Cash & Cash Equivalents	17.96M
Total Debt	20.57M
Net Cash	-2.61M
Retained Earnings	-23.97M
Total Assets	67.91M
Working Capital	7.23M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -612.19K and capital expenditures -179.71K, giving a free cash flow of -791.9K.

Operating Cash Flow	-612.19K
Capital Expenditures	-179.71K
Free Cash Flow	-791.9K
FCF Per Share	-0.06

Full Cash Flow Statement

Margins

Gross margin is 82.61%, with operating and profit margins of -16.99% and -17.11%.

Gross Margin	82.61%
Operating Margin	-16.99%
Pretax Margin	-17.08%
Profit Margin	-17.11%
EBITDA Margin	0.48%
EBIT Margin	-16.99%
FCF Margin	-2.09%

Dividends & Yields

CPIX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for CPIX.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	0.83
Piotroski F-Score	5